ArticleeLife2025

Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells.

Yu-Chia Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.